drugset / Trial / NCT02121834
A Study of LY3050258 in Healthy Participants
RandomizedParallel-groupDouble-blindBasic science
Summary
This is a multiple dose study of LY3050258 in healthy men and postmenopausal women. This study will evaluate the safety and how well the body tolerates LY3050258. It will last approximately 14 weeks with a 2 week follow-up appointment after the last treatment with study drug.
Timeline
- Start
- 2014-06
- Primary completion
- 2014-12
- Completion
- 2014-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY3050258 | Unknown | 10 mg | — |
| Subject | LY3050258 | Unknown | 30 mg | — |
| Subject | LY3050258 | Unknown | 90 mg | — |
| Subject | LY3050258 | Unknown | 180 mg | — |
| Subject | LY3050258 | Unknown | 360 mg | — |
Indications
No indication recorded.